Welgus Howard G.: insider trades.
Welgus Howard G. reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($365K), across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Welgus Howard G.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Director | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Arcutis Biotherapeutics, Inc. | M | 822 | $6.52 | 37,297 | Form 4 |
| 2026-09-15 | Arcutis Biotherapeutics, Inc. | S | 4,730 | $24.18 | 35,841 | Form 4 |
| 2026-09-15 | Arcutis Biotherapeutics, Inc. | M | 2,255 | $8.63 | 40,571 | Form 4 |
| 2026-09-15 | Arcutis Biotherapeutics, Inc. | M | 1,019 | $7.51 | 38,316 | Form 4 |
| 2026-08-17 | Arcutis Biotherapeutics, Inc. | M | 2,255 | $8.63 | 41,205 | Form 4 |
| 2026-08-17 | Arcutis Biotherapeutics, Inc. | M | 1,019 | $7.51 | 38,950 | Form 4 |
| 2026-08-17 | Arcutis Biotherapeutics, Inc. | M | 822 | $6.52 | 37,931 | Form 4 |
| 2026-08-17 | Arcutis Biotherapeutics, Inc. | S | 4,730 | $26.18 | 36,475 | Form 4 |
| 2026-07-15 | Arcutis Biotherapeutics, Inc. | M | 2,255 | $8.63 | 41,839 | Form 4 |
| 2026-07-15 | Arcutis Biotherapeutics, Inc. | S | 4,730 | $26.91 | 37,109 | Form 4 |
| 2026-07-15 | Arcutis Biotherapeutics, Inc. | M | 1,019 | $7.51 | 39,584 | Form 4 |
| 2026-07-15 | Arcutis Biotherapeutics, Inc. | M | 822 | $6.52 | 38,565 | Form 4 |
Questions
What stock did Welgus Howard G. buy or sell?
Welgus Howard G. reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($365K), across 1 company.
Is Welgus Howard G. the same person as other filers with this name?
This page covers SEC CIK 1801050 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/welgus-howard-g-1801050.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.